Theravance Biopharma (TBPH) Income from Discontinued Operations (2021 - 2023)
Theravance Biopharma (TBPH) posted quarterly Income from Discontinued Operations of 400000.0 for Q1 2023, up 110.27% quarter-over-quarter from 3894000.0 in Q4 2022.
Powered by 
Analysis
Theravance Biopharma (TBPH) Income from Discontinued Operations (2021 - 2023) Analysis & Trends
Theravance Biopharma (TBPH) has reported Income from Discontinued Operations for 2 consecutive years, with 400000.0 the latest figure, recorded in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Theravance Biopharma | 882.47 Mn | 494.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 400,000.00 |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | 927.09 Mn |
| Jun 30, 2022 | 18.38 Mn |
| Mar 31, 2022 | 15.59 Mn |
| Dec 31, 2021 | 25.78 Mn |
| Sep 30, 2021 | 20.60 Mn |
| Jun 30, 2021 | 12.45 Mn |
| Mar 31, 2021 | 6.81 Mn |